# clm_6D0F6FB5867B

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: research_and_development  
value: 5,243,900,000 United States dollar  
valid_from: 2016-12-31  
valid_to: 2017-12-31  
published: 2017-02-21  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_1D6D085414BC  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company research and development: 5,243,900,000 United States dollar", as of 2016-12-31 (until 2017-12-31). Claim clm_6D0F6FB5867B, https://asof.is/claim/clm_6D0F6FB5867B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947817000098/0000059478-17-000098-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2016, filed 2017-02-21  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947817000098/0000059478-17-000098-index.htm (primary, SEC EDGAR 10-K FY2016, published 2017-02-21)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | research_and_development | 4,796,400,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_6D0F6FB5867B](/claim/clm_6D0F6FB5867B.md) | [clm_1B276AE2739D](/claim/clm_1B276AE2739D.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.